abilify- aripiprazole tablet
carilion materials management - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: abilify injection is indicated for the treatment of: abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2) ] . pregnancy category c pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abilify during pregnancy. for more information contact the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/. risk summary neonates exposed to antipsychotic drugs (including abilify) during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms. adequate and well controlled studies with abilify have not been conducted in pregnant women. animal reproduction studies were con
abilify- aripiprazole tablet
bryant ranch prepack - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 5 mg - abilify oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia [see clinical studies (14.1)] - acute treatment of manic and mixed episodes associated with bipolar i disorder [see clinical studies (14.2)] - adjunctive treatment of major depressive disorder [see clinical studies (14.3)] - irritability associated with autistic disorder [see clinical studies (14.4)] - treatment of tourette's disorder [see clinical studies (14.5)] abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania [see clinical studies (14.6)] abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare pro
abilify- aripiprazole tablet
carilion materials management - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - abilify oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: abilify injection is indicated for the treatment of: abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2) ] . pregnancy category c pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abilify during pregnancy. for more information contact the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/. risk summary neonates exposed to antipsychotic drugs (including abilify) during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms. adequate and well controlled studies with abilify have not been conducted in pregnant women. animal reproduction studies were con
abilify- aripiprazole tablet
carilion materials management - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - abilify oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: abilify injection is indicated for the treatment of: abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2) ] . pregnancy category c pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abilify during pregnancy. for more information contact the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/. risk summary neonates exposed to antipsychotic drugs (including abilify) during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms. adequate and well controlled studies with abilify have not been conducted in pregnant women. animal reproduction studies were con
livazo tablets film-coated
recordati industria chimica e farmaceutica s.p.a. - pitavastatin (pitavastatin calcium) - tablets film-coated - 1mg
aripiprazole sandoz
sandoz gmbh - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - aripiprazole sandoz is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole sandoz is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment. aripiprazole sandoz is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.,
vitamin c tablets
replek farm ltd - ascorbic acid - tablets - 500mg
auro-aripiprazole tablet
auro pharma inc - aripiprazole - tablet - 20mg - aripiprazole 20mg - atypical antipsychotics
teva-aripiprazole tablet
teva canada limited - aripiprazole - tablet - 20mg - aripiprazole 20mg - atypical antipsychotics
pms-aripiprazole tablet
pharmascience inc - aripiprazole - tablet - 20mg - aripiprazole 20mg - atypical antipsychotics